Diagnostic and Interventional Cardiology

Socioeconomic status (education, income, employment status and health insurance) appears to be an uneven predictor of heart health with white adults benefitting the most in comparison to Black, Hispanic and Asian Americans

Ohio State Study Shows Socioeconomic Status May Be An Uneven Predictor of Heart Health

September 13, 2023 — Socioeconomic status (education, income, employment status and health insurance) appears to be an ...

September 13, 2023

The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence in adult and pediatric extracorporeal membrane oxygenation

News | ECMO Systems

Smidt Heart Institute’s ECMO Expertise Awarded

September 13, 2023 — The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence ...

September 13, 2023

The analysis of the health records found that, on average, participants’ systolic blood pressure increased by up to 1.7 mm Hg in the winter months compared to the summer months

News | Hypertension

Study from AHA Hypertension Scientific Sessions Reports on Cold Weather’s Impact on Treating High Blood Pressure

September 13, 2023 — Blood pressure among patients diagnosed with hypertension appeared to slightly increase, and rates ...

September 13, 2023

Sponsored Content

Blog | Contrast Media Injectors

BLOG: Enhancing Efficiency and Patient Care with a Modern Injector

Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...

August 22, 2023

Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of lorundrostat, a highly selective aldosterone synthase inhibitor, in individuals with uncontrolled hypertension (uHTN) and resistant hypertension (rHTN).

News | Cardiovascular Clinical Studies

Mineralys Therapeutics Presents Target-HTN Phase 2 Trial Results at 2023 AHA Hypertension Scientific Sessions

September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of ...

September 12, 2023

Interim results from SOTERIA open-label extension study represent longest safety and efficacy analysis of sotatercept to date

News | Cardiovascular Clinical Studies

Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension (PAH)

September 12, 2023 — Merck announced new analyses from studies of sotatercept, Merck’s novel investigational activin ...

September 12, 2023

The global interventional cardiology device market is driven by the number of procedures performed across the globe

Feature | Cardiovascular Business | By Emily Gilbert and Kamran Zamanian, PhD

The New Interventional Cardiology Market

The global interventional cardiology device market is driven by the number of procedures performed across the globe. The ...

September 12, 2023

Sponsored Content

As medical advancements continue to push the boundaries of what is possible in the field of structural heart interventions, the importance of enterprise imaging has become increasingly evident.

Blog | Enterprise Imaging

BLOG: The Power of Enterprise Imaging in Structural Heart Procedures

As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...

August 10, 2023

UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients, single-ventricle physiology correlated with higher short-term mortality

News | Congenital Heart

UCLA Research Suggests that Heart Transplantation is Safer for Adults with Single-ventricle CHD than Previously Thought

September 12, 2023 — UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients ...

September 12, 2023

Quality Improvement and Education Program sponsored by Amgen, Esperion to improve adherence to guideline recommendations for managing LDL

News | ACC

American College of Cardiology Program to Increase Cholesterol Screenings

September 12, 2023 — The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is ...

September 12, 2023

Videos | Pharmaceuticals

VIDEO, Part 2: Hypertrophic Cardiomyopathy in Focus

In Part 2 of DAIC’s 3-part “One on One” series with Dr. Christine Seidman, a discussion on the discovery of gene-based ...

September 11, 2023

Sponsored Content

Case Study | Enterprise Imaging

Re-Architecting a Hemo System Using Behavioral Science

Behavioral science is being applied in unique ways for enterprise imaging product design. Involving clinicians in the ...

May 30, 2023

Premier cardiovascular digital health experience continues cultivating a community to examine and solve for future complex healthcare needs

News | Cardiovascular Business

HRX 2023 Conference Propelling the Future of Digital Health

September 11, 2023 — The Heart Rhythm Society (HRS) is gearing up for its second annual HRX event, bringing ...

September 11, 2023

The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR

News | Drug-Eluting Balloons

MedAlliance Announces Enrollment of First Patient in SELUTION SLR LOVE-DEB Coronary Study

September 11, 2023 — The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease ...

September 11, 2023

Regulatory and quality leader brings decades of global SaMD experience to guide leading AI-powered cardiovascular diagnostic company through growth and expansion

News | Cardiovascular Business

Elucid Appoints Windi Hary to Lead Regulatory Affairs and Quality Management

September 11, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

September 11, 2023

Sponsored Content

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the wealth of technological advancements, bringing the necessary tools together in a streamlined workflow has remained a challenge for clinicians

Case Study | Baylor Scott and White Heart Hospital

Contemporary PCI: Utilizing State-of-the-Art Technology to Achieve the Best Outcomes

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...

May 05, 2023

the Company is exploring development of a new Phase III clinical trial protocol

News | Heart Failure

BioCardia Announces Clarification and Next Steps on its Autologous CardiAMP Cell Therapy Programs

September 8, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

September 08, 2023

MPROVE-ISCHEMIA, a randomized, placebo-controlled trial, with topline data expected in 4Q 2023

News | Cardiovascular Clinical Studies

Imbria Pharmaceuticals Completes Enrollment in the Phase 2 IMPROVE-ISCHEMIA Clinical Trial of Ninerafaxstat in Patients with Stable Angina

September 8, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company dedicated to developing ...

September 08, 2023

Patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have clinically actionable variants in DCM genes than those of European ancestry

News | Cardiovascular Clinical Studies

Study Highlights Need for Diversity in Clinical Trials to Better Understand, Treat Inherited Heart Muscle Disease

September 8, 2023 — Patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have clinically ...

September 08, 2023